Filling the gap in CNS drug development: evaluation of the role of drug repurposing
Background and objective: Background and objective: Drug repurposing has been considered a cost-effective and reduced-risk strategy for developing new drugs. Little is known and documented regarding the efficiency of repurposing strategies in drug development. The objective of this article is to ass...
Saved in:
Main Authors: | A. Caban (Author), K. Pisarczyk (Author), K. Kopacz (Author), A. Kapuśniak (Author), M. Toumi (Author), C. Rémuzat (Author), A. Kornfeld (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prospects for repurposing CNS drugs for cancer treatment
by: Mohamed Abdelaleem, et al.
Published: (2019) -
Value added medicines: what value repurposed medicines might bring to society?
by: Mondher Toumi, et al.
Published: (2017) -
Supply-side and demand-side policies for biosimilars: an overview in 10 European member states
by: Cécile Rémuzat, et al.
Published: (2017) -
Combating COVID-19: The role of drug repurposing and medicinal plants
by: Shah A. Khan, et al.
Published: (2021) -
Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing
Published: (2022)